Plasmodium falciparum heme detoxification pathway (HDP pathway) (HDP)

The Plasmodium falciparum heme detoxification pathway is a vital metabolic process required for the survival of the malaria parasite during its intraerythrocytic developmental stage (Jani et al., 2008, PLoS Pathogens). As the parasite consumes host hemoglobin to obtain essential amino acids, it releases ferriprotoporphyrin IX (free heme), a toxic byproduct that can cause lethal oxidative damage and membrane lysis (Egan, 2008, Future Microbiology). To mitigate this toxicity, the parasite utilizes a biocrystallization process within its acidic digestive vacuole to convert free heme into an insoluble, chemically inert polymer called hemozoin, or β-hematin (Coronado et al., 2014, Biochimica et Biophysica Acta). This pathway is the primary target for several major classes of antimalarial drugs, including 4-aminoquinolines like chloroquine and quinoline methanols like quinine (Sullivan, 2002, Current Drug Targets). These drugs act by binding to heme monomers or the growing crystal surface, thereby preventing detoxification and causing the accumulation of lethal levels of free heme within the parasite (Hempelmann, 2007, Parasitology Research). Because this detoxification mechanism is unique to the Plasmodium genus and absent in human hosts, it remains a cornerstone of antimalarial chemotherapy, despite the significant challenge posed by the global spread of resistant parasite strains (Wellems & Plowe, 2001, Journal of Infectious Diseases).

Other names

Hemozoin formation pathwayβ-hematin crystallization pathwayHeme biocrystallizationMalaria pigment formationHemoglobin degradation pathway

Inhibition of the conversion of toxic free heme (ferriprotoporphyrin IX) into non-toxic, insoluble hemozoin crystals (β-hematin), leading to parasite death via oxidative stress and membrane damage (Sullivan, 2002, Current Drug Targets).